Biohaven reports positive topline results from zydis study
Biohaven Pharmaceutical has reported positive topline results from the Phase III BHV3000-303 or Study 303 clinical trial.
Biohaven Pharmaceutical has reported positive topline results from the Phase III BHV3000-303 or Study 303 clinical trial.
Thank you for subscribing to Clinical Trials Arena